See every side of every news story
Published loading...Updated

2 Beaten-Down Stocks to Buy on the Dip - Overpasses For America

Summary by overpassesforamerica.com
CRISPR Therapeutics (NASDAQ: CRSP) and Merck (NYSE: MRK), two companies that develop innovative medical therapies. Vertex Pharmaceuticals, with which it developed the medicine; Vertex is entitled to 60% of the program profits. Story Continues pharmaceutical giant. Keytruda’s sales were $29.5 billion, up 18% year over year; the drug accounted for about 46% of Merck’s top line. That’s why the market is spooked: Losing Keytruda could be a catastro…

Bias Distribution

  • 100% of the sources lean Right
100% Right
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

overpassesforamerica.com broke the news in on Saturday, March 22, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.